SPR Therapeutics wins $10m from the DoD

SPR Therapeutics said yesterday it received $10 million from two new grants and a contract from the US Dept. of Defense, all to support its percutaneous peripheral nerve stimulation therapy intended as a non-opioid pain relief therapy for both acute and chronic pain. The new awards bring the total number of grants and contracts the Cleveland, Ohio-based company has received up to $30 million. “The need among pain management physicians for non-opioid, minimally invasive and user-friendly treatment options is great. The funding provided by the Defense Department will provide additional data and insight regarding the Sprint system’s ability to improve quality of life, enable faster post-operative recovery and provide long-term pain relief,” American Society of Pain and Neuroscience prez Dr. Dawood Sayed said in a prepared statement. The largest of the awards was a $6 million grant to support a randomized controlled trial which aims to compare the Sprint PNS system to conventional medical management, exploring its ability to reduce pain and opioid use and improve functionality amongst Service members, the company said. SPR Therapeutics said it received a separate $3 million grant to support another randomized controlled trial which will explore the use of the Sprint PNS system for pain management following surgery for both combat and non-combat related orthopedic trauma. The company said it also received a $1 million contract to fund continued development of its P...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Clinical Trials Pain Management SPR Therapeutics Source Type: news